Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai - Orient Cables (India) Limited Announced its ₹5,520.00 million Initial Public Offering (IPO) to open on September 25, 2026 Price Band fixed at ₹258 to ₹272 per equity share of face value of ₹1 each - AceVector Limited Announced it's Initial Public Offer (IPO) of Equity Shares to open on September 25, 2026, Price Band is fixed at ₹ 30 to ₹ 32 per equity share of face value of ₹ 1 each - Moneyview Limited announced its Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - Moneyview Limited announced it's Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - BVG India awarded contract of Chambal Riverfront to Develop a Destination for Sustainable Urban Living and Tourism - L’Oréal Paris to Host Le Défilé at The Eiffel tower, Celebrating Sisterhood, Diversity and Inclusion - Elevate Campuses Limited Announced its ₹2100 crore Initial Public Offering (IPO) to open on Wednesday, September 23, 2026 Price Band fixed at ₹343 to ₹362 per shareBid/Issue Opening Date – Wednesday, September 23, 2026 and Bid/Issue Closing Date – Friday, September 25, 2026 - VARMORA GRANITO LIMITED IPO TO OPEN ON TUESDAY, SEPTEMBER 22, 2026Price Band fixed at ₹140 to ₹148 per equity share of face value of ₹2 each - "Breath of Hope”: Mumbai Doctors Help Paralysed Man Breathe Independently After Six Months on a Ventilator

Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai

Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai

~ Haploidentical bone marrow transplant, led by Consultant Haemato-oncologist Dr. Kunal Goyal, gives a five-year-old boy a second chance at life after his cancer relapsed and doctors elsewhere had run out of treatment options.

Navi Mumbai, September 22, 2026: A five-year-old boy from Ranchi who had been placed on palliative care after his leukemia returned is now in remission, following treatment at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai. Led by Consultant Haemato-oncologist Dr. Kunal Goyal, the child’s care combined targeted immunotherapy with a haploidentical (half-matched) bone marrow transplant to bring his cancer under control.

The child was first diagnosed at age five, after his parents noticed bruising on his legs and swelling in his neck. Blood tests led to a diagnosis of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia, a high-risk form of blood cancer marked by two genetic changes, an IKZF1 mutation and monosomy 7, both associated with poor outcomes.

His previous treatment at other hospitals included multiple rounds of chemotherapy, targeted medicines, and radiation to the brain to keep the cancer from spreading there. Traces of the disease persisted despite months of treatment, and he was put on a more intensive regimen before starting maintenance chemotherapy. After about six months of maintenance treatment, his blood counts dropped sharply. A bone marrow test confirmed that the leukemia had relapsed, and he was placed on palliative care, meaning specialised non-curative care focused on easing symptoms such as pain.

However, his parents did not give up hope. Searching for other options, they brought the child to Dr. Kunal Goyal, Haemato-oncologist, BMT and Cellular Therapies (CAR-T) at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai. Under his care, the child received targeted immunotherapy that brought his disease down to nearly undetectable levels, clearing him for a haploidentical bone marrow transplant using a half-matched family donor.

Dr. Kunal Goyal, Consultant, Haemato-oncologist, BMT and Cellular Therapies (CAR-T) at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, said, “When the child came to us, his disease had relapsed and his family had been told there was nothing left to try. One can imagine the impact of this on the parents of a five-year-old. Getting him into remission with immunotherapy, and then safely through a haploidentical transplant, took a coordinated effort from our entire multi-speciality team, from the BMT unit to critical care. Seeing him go home healthy is exactly why we do this work.”

Recovery was not without its challenges. The child developed a high fever linked to his weakened immune system and had a severe allergic reaction to a blood transfusion. He also developed respiratory distress and gut infections. Under the expertise of the Paediatric team led by Dr. Shilpa Aroskar, Head – Pediatrics and Neonatology, along with Dr. Goyal, these complications were promptly treated. The child has since recovered and returned home.

Dr. Shilpa Aroskar adds, “Managing childhood leukemia demands expertise, precision and preparedness. Our Paediatric team, working hand-in-hand with the Haematology transplant team at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, is equipped to take that journey—from advanced therapies like CAR-T to BMT, with one goal – giving every child the best chance at a healthier tomorrow.”

“Stories like this keep inspiring us to bring the best of modern medicine to Navi Mumbai. We have built up world-class bone marrow transplant and cellular therapy capabilities here in Navi Mumbai,” said Dr. Shashikant Pawar, Chief Operating Officer, Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai. “We believe that families should never be put in a situation where they run out of options to access the best of care for their child. We will continue to offer advanced treatments like haploidentical transplants and CAR-T therapy, and to invest in the doctors and technology that make outcomes like this possible.”ends GNI

Be the first to comment on "Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai"

Leave a comment

Your email address will not be published.


*